Literature DB >> 11463826

Inhibition of the motility and growth of B16F10 mouse melanoma cells by dominant negative mutants of Dok-1.

T Hosooka1, T Noguchi, H Nagai, T Horikawa, T Matozaki, M Ichihashi, M Kasuga.   

Abstract

Dok-1 (p62(Dok)) is a multiple-site docking protein that acts downstream of receptor and nonreceptor tyrosine kinases. Although it has been proposed to contribute to the control of cell growth and migration through association with the Ras GTPase-activating protein and the adapter protein Nck, the role of Dok-1 remains largely unknown. The functions of Dok-1 have now been investigated by the generation of two different COOH-terminal truncation mutants of this protein: one (DokPH+PTB) containing the pleckstrin homology and phosphotyrosine-binding domains, and the other (DokPH) composed only of the pleckstrin homology domain. Both of these mutant proteins were shown to act in a dominant negative manner. Overexpression of each of the mutants in highly metastatic B16F10 mouse melanoma cells thus both inhibited the tyrosine phosphorylation of endogenous Dok-1 induced by cell adhesion as well as reduced the association of the endogenous protein with cellular membranes and the cytoskeleton. Overexpression of DokPH+PTB in these cells also markedly reduced both the rates of cell spreading, migration, and growth as well as the extent of Ras activation. The effects of DokPH on these processes were less pronounced than were those of DokPH+PTB, indicating the importance of the phosphotyrosine-binding domain. These results suggest that at least in B16F10 cells, Dok-1 positively regulates not only cell spreading and migration but also cell growth and Ras activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11463826      PMCID: PMC87266          DOI: 10.1128/MCB.21.16.5437-5446.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  48 in total

1.  Stimulation of the high-affinity IgE receptor results in the tyrosine phosphorylation of a 60 kD protein which is associated with the protein-tyrosine kinase, Csk.

Authors:  T Rafnar; R S Peebles; M E Brummet; B Catipović; F Imani; D W MacGlashan; D G Marsh
Journal:  Mol Immunol       Date:  1998-03       Impact factor: 4.407

2.  Ras-GAP controls Rho-mediated cytoskeletal reorganization through its SH3 domain.

Authors:  V Leblanc; B Tocque; I Delumeau
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

3.  Activation of Pak by membrane localization mediated by an SH3 domain from the adaptor protein Nck.

Authors:  W Lu; S Katz; R Gupta; B J Mayer
Journal:  Curr Biol       Date:  1997-02-01       Impact factor: 10.834

Review 4.  The IRS-signalling system: a network of docking proteins that mediate insulin action.

Authors:  M F White
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

5.  Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins.

Authors:  A Di Cristofano; N Carpino; N Dunant; G Friedland; R Kobayashi; A Strife; D Wisniewski; B Clarkson; P P Pandolfi; M D Resh
Journal:  J Biol Chem       Date:  1998-02-27       Impact factor: 5.157

6.  Induced direct binding of the adapter protein Nck to the GTPase-activating protein-associated protein p62 by epidermal growth factor.

Authors:  J Tang; G S Feng; W Li
Journal:  Oncogene       Date:  1997-10-09       Impact factor: 9.867

7.  FRIP, a hematopoietic cell-specific rasGAP-interacting protein phosphorylated in response to cytokine stimulation.

Authors:  K Nelms; A L Snow; J Hu-Li; W E Paul
Journal:  Immunity       Date:  1998-07       Impact factor: 31.745

8.  Differential effects of B cell receptor and B cell receptor-FcgammaRIIB1 engagement on docking of Csk to GTPase-activating protein (GAP)-associated p62.

Authors:  M Vuica; S Desiderio; J P Schneck
Journal:  J Exp Med       Date:  1997-07-21       Impact factor: 14.307

9.  Regulation of cell motility by mitogen-activated protein kinase.

Authors:  R L Klemke; S Cai; A L Giannini; P J Gallagher; P de Lanerolle; D A Cheresh
Journal:  J Cell Biol       Date:  1997-04-21       Impact factor: 10.539

10.  Integrin-mediated signals regulated by members of the rho family of GTPases.

Authors:  E A Clark; W G King; J S Brugge; M Symons; R O Hynes
Journal:  J Cell Biol       Date:  1998-07-27       Impact factor: 10.539

View more
  15 in total

1.  Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling.

Authors:  David A Calderwood; Yosuke Fujioka; Jose M de Pereda; Begoña García-Alvarez; Tetsuya Nakamoto; Ben Margolis; C Jane McGlade; Robert C Liddington; Mark H Ginsberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-26       Impact factor: 11.205

2.  Chemical groups that adhere to the surfaces of living malignant cells.

Authors:  Cathy E McNamee; Yuki Aso; Shinpei Yamamoto; Yoshinobu Fukumori; Hideki Ichikawa; Ko Higashitani
Journal:  Pharm Res       Date:  2007-09-12       Impact factor: 4.200

3.  Atomic force microscopy study of the specific adhesion between a colloid particle and a living melanoma cell: Effect of the charge and the hydrophobicity of the particle surface.

Authors:  Cathy E McNamee; Nayoung Pyo; Ko Higashitani
Journal:  Biophys J       Date:  2006-05-26       Impact factor: 4.033

4.  Transcriptional regulation of the human tumor suppressor DOK1 by E2F1.

Authors:  Maha Siouda; Jiping Yue; Ruchi Shukla; Sophie Guillermier; Zdenko Herceg; Marion Creveaux; Rosita Accardi; Massimo Tommasino; Bakary S Sylla
Journal:  Mol Cell Biol       Date:  2012-10-01       Impact factor: 4.272

5.  Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer.

Authors:  Pierre-Luc Mercier; Magdalena Bachvarova; Marie Plante; Jean Gregoire; Marie-Claude Renaud; Karim Ghani; Bernard Têtu; Isabelle Bairati; Dimcho Bachvarov
Journal:  Mol Oncol       Date:  2011-07-26       Impact factor: 6.603

6.  CAV1 inhibits metastatic potential in melanomas through suppression of the integrin/Src/FAK signaling pathway.

Authors:  Casey Trimmer; Diana Whitaker-Menezes; Gloria Bonuccelli; Janet N Milliman; Kristin M Daumer; Andrew E Aplin; Richard G Pestell; Federica Sotgia; Michael P Lisanti; Franco Capozza
Journal:  Cancer Res       Date:  2010-08-13       Impact factor: 12.701

7.  A unique autophosphorylation site on Tie2/Tek mediates Dok-R phosphotyrosine binding domain binding and function.

Authors:  Nina Jones; Stephen H Chen; Celina Sturk; Zubin Master; Jennifer Tran; Robert S Kerbel; Daniel J Dumont
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

8.  A nuclear export signal and phosphorylation regulate Dok1 subcellular localization and functions.

Authors:  Yamei Niu; François Roy; Frédéric Saltel; Charlotte Andrieu-Soler; Wen Dong; Anne-Lise Chantegrel; Rosita Accardi; Amélie Thépot; Nadège Foiselle; Massimo Tommasino; Pierre Jurdic; Bakary S Sylla
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

9.  IkappaB kinase beta phosphorylates Dok1 serines in response to TNF, IL-1, or gamma radiation.

Authors:  Sanghoon Lee; Charlotte Andrieu; Frédéric Saltel; Olivier Destaing; Jessie Auclair; Véronique Pouchkine; Jocelyne Michelon; Bruno Salaun; Ryuji Kobayashi; Pierre Jurdic; Elliott D Kieff; Bakary S Sylla
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-01       Impact factor: 11.205

Review 10.  Advances in targeting IKK and IKK-related kinases for cancer therapy.

Authors:  Dung-Fang Lee; Mien-Chie Hung
Journal:  Clin Cancer Res       Date:  2008-09-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.